國立高雄大學圖資館 |

Language: English

Back

IgG4-related sclerosing cholangitis

Kamisawa, Terumi.

IgG4-related sclerosing cholangitis

Record Type:	Electronic resources : Monograph/item
Title/Author:	IgG4-related sclerosing cholangitisedited by Terumi Kamisawa, Myung-Hwan Kim.
other author:	Kamisawa, Terumi.
Published:	Singapore :Springer Singapore :2019.
Description:	viii, 142 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Bile ductsDiseases.
Online resource:	http://dx.doi.org/10.1007/978-981-10-4548-6
ISBN:	9789811045486$q(electronic bk.)

IgG4-related sclerosing cholangitis
IgG4-related sclerosing cholangitis[electronic resource] /edited by Terumi Kamisawa, Myung-Hwan Kim. - Singapore :Springer Singapore :2019. - viii, 142 p. :ill., digital ;24 cm.

O verview including classification of sclerosing cholangitis -- Epidemiology -- Pathophysiology -- Pathology -- Clinical features -- Serology -- Diagnostic criteria -- Imaging -- 1) US and CT -- 2) MRI with MRCP -- 3) ERCP -- 4) EUS and IDUS -- Differential diagnosis from primarysclerosing cholangitis -- Differential diagnosis from cholangiocarcinoma -- Tissue acquisition for histologic diagnosis -- Other organ involvements including autoimmune pancreatitis -- Treatment -- 1) Steroids -- 2) Immunomodulatory drugs -- 3) Rituximab -- Prognosis -- IgG4-related sclerosing cholangitis in America -- IgG4-related sclerosing cholangitis in Europe -- IgG4-related disease.

This book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.

ISBN: 9789811045486$q(electronic bk.)

Standard No.: 10.1007/978-981-10-4548-6doiSubjects--Topical Terms:

771370
Bile ducts
--Diseases.

LC Class. No.: RC849

Dewey Class. No.: 616.365

IgG4-related sclerosing cholangitis
LDR:02658nmm a2200313 a 4500 001 551422
003 DE-He213
005 20180731120552.0
006 m d
007 cr nn 008maaau
008 191024s2019 si s 0 eng d
020 $a 9789811045486$q(electronic bk.)
020 $a 9789811045479$q(paper)
024 7 $a 10.1007/978-981-10-4548-6 $2 doi
035 $a 978-981-10-4548-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC849
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
082 0 4 $a 616.365 $2 23
090 $a RC849 $b .I24 2019
245 0 0 $a IgG4-related sclerosing cholangitis $h [electronic resource] / $c edited by Terumi Kamisawa, Myung-Hwan Kim.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a viii, 142 p. : $b ill., digital ; $c 24 cm.
505 0 $a O verview including classification of sclerosing cholangitis -- Epidemiology -- Pathophysiology -- Pathology -- Clinical features -- Serology -- Diagnostic criteria -- Imaging -- 1) US and CT -- 2) MRI with MRCP -- 3) ERCP -- 4) EUS and IDUS -- Differential diagnosis from primarysclerosing cholangitis -- Differential diagnosis from cholangiocarcinoma -- Tissue acquisition for histologic diagnosis -- Other organ involvements including autoimmune pancreatitis -- Treatment -- 1) Steroids -- 2) Immunomodulatory drugs -- 3) Rituximab -- Prognosis -- IgG4-related sclerosing cholangitis in America -- IgG4-related sclerosing cholangitis in Europe -- IgG4-related disease.
520 $a This book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.
650 0 $a Bile ducts $x Diseases. $3 771370
650 0 $a Immunoglobulin G. $3 763252
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Internal Medicine. $3 273839
700 1 $a Kamisawa, Terumi. $3 712576
700 1 $a Kim, Myung-Hwan. $3 831523
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-4548-6
950 $a Medicine (Springer-11650)